A new trading day began on Tuesday, with Ocular Therapeutix Inc (NASDAQ: OCUL) stock price down -1.94% from the previous day of trading, before settling in for the closing price of $9.28. OCUL’s price has ranged from $5.78 to $11.77 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 8.51%. Meanwhile, its annual earnings per share averaged -17.19%. With a float of $133.28 million, this company’s outstanding shares have now reached $159.26 million.
Let’s determine the extent of company efficiency that accounts for 274 employees. In terms of profitability, gross margin is 90.66%, operating margin of -342.52%, and the pretax margin is -323.44%.
Ocular Therapeutix Inc (OCUL) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ocular Therapeutix Inc is 16.33%, while institutional ownership is 74.32%. The most recent insider transaction that took place on Jun 02 ’25, was worth 111,581. In this transaction Chief Medical Officer of this company sold 13,861 shares at a rate of $8.05, taking the stock ownership to the 206,805 shares. Before that another transaction happened on Jun 02 ’25, when Company’s Officer proposed sale 13,861 for $8.05, making the entire transaction worth $111,524.
Ocular Therapeutix Inc (OCUL) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -17.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.11% during the next five years compared to 8.51% growth over the previous five years of trading.
Ocular Therapeutix Inc (NASDAQ: OCUL) Trading Performance Indicators
Here are Ocular Therapeutix Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 24.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.39 in one year’s time.
Technical Analysis of Ocular Therapeutix Inc (OCUL)
Looking closely at Ocular Therapeutix Inc (NASDAQ: OCUL), its last 5-days average volume was 2.83 million, which is a jump from its year-to-date volume of 1.7 million. As of the previous 9 days, the stock’s Stochastic %D was 65.70%.
During the past 100 days, Ocular Therapeutix Inc’s (OCUL) raw stochastic average was set at 78.65%, which indicates a significant increase from 54.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.19% in the past 14 days, which was lower than the 80.12% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.10, while its 200-day Moving Average is $8.47. However, in the short run, Ocular Therapeutix Inc’s stock first resistance to watch stands at $9.33. Second resistance stands at $9.56. The third major resistance level sits at $9.70. If the price goes on to break the first support level at $8.96, it is likely to go to the next support level at $8.82. Should the price break the second support level, the third support level stands at $8.59.
Ocular Therapeutix Inc (NASDAQ: OCUL) Key Stats
With a market capitalization of 1.45 billion, the company has a total of 159,300K Shares Outstanding. Currently, annual sales are 63,720 K while annual income is -193,510 K. The company’s previous quarter sales were 10,700 K while its latest quarter income was -64,050 K.
